Status:

UNKNOWN

Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia

Lead Sponsor:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborating Sponsors:

Vifor Pharma

Conditions:

Anemia

Colorectal Carcinoma

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The aim of this multicenter trial is to determine the efficacy of preoperative intravenous iron suppletion in comparison with the standard preoperative oral substitution in anaemic patients with color...

Detailed Description

This multicenter randomized clinical trial aims to optimize postoperative outcome in anaemic patients who undergo curative surgery for colorectal carcinoma. The aim of this trial is to investigate whi...

Eligibility Criteria

Inclusion

  • M0-stage Colorectal carcinoma
  • Laparoscopic or open segmental colonic resection or (low) anterior resection
  • Iron deficiency anaemia: Hb \<7,5 mmol/l (12 g/dl) for women and Hb \< 8 mmol/l (13 g/dl) for men and TSAT\<20%
  • Age 18 or older
  • Written informed consent for study participation

Exclusion

  • Palliative surgery / metastasized disease
  • Received blood transfusion within one month before screening
  • Serum ferritin ≥ 800 µg/L
  • Pregnancy
  • Preoperative chemoradiation (Short course radiotherapy (5x5 Gy) = no exclusion)
  • Contraindication for the use of ferric(III)carboxymaltose or ferrofumarate
  • ASA classification \> 3
  • Use of erythropoietin stimulating agents within three months before screening
  • Chronic kidney disease (GFR \< 30ml/min/m)
  • Myelodysplastic syndrome
  • Severe anaemia with indication for blood transfusion
  • Elevated liver enzymes (more than three times normal value)
  • Hereditary Hemochromatosis
  • Thalassemia
  • Haemolytic anaemia/ chronic haemolysis

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2019

Estimated Enrollment :

198 Patients enrolled

Trial Details

Trial ID

NCT02243735

Start Date

November 1 2014

End Date

December 1 2019

Last Update

August 28 2018

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Medisch Centrum Alkmaar

Alkmaar, Netherlands

2

Flevoziekenhuis

Almere Stad, Netherlands

3

Meander Ziekenhuis

Amersfoort, Netherlands

4

Academic Medical Center

Amsterdam, Netherlands, 1100DD

Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia | DecenTrialz